Literature DB >> 22975872

Plasmacytoid dendritic cells in HIV infection.

Meagan O'Brien1, Olivier Manches, Nina Bhardwaj.   

Abstract

Plasmacytoid dendritic cells (pDCs) are innate immune cells that are specialized to produce interferon-alpha (IFNα) and participate in activating adaptive immune responses. Although IFNα inhibits HIV-1 (HIV) replication in vitro, pDCs may act as inflammatory and immunosuppressive dendritic cells (DCs) rather than classical antigen-presenting cells during chronic HIV infection in vivo, contributing more to HIV pathogenesis than to protection. Improved understanding of HIV-pDC interactions may yield potential new avenues of discovery to prevent HIV transmission, to blunt chronic immune activation and exhaustion, and to enhance beneficial adaptive immune responses. In this chapter we discuss pDC biology, including pDC development from progenitors, trafficking and localization of pDCs in the body, and signaling pathways involved in pDC activation. We focus on the role of pDCs in HIV transmission, chronic disease progression and immune activation, and immunosuppression through regulatory T cell development. Lastly, we discuss potential future directions for the field which are needed to strengthen our current understanding of the role of pDCs in HIV transmission and pathogenesis.

Entities:  

Mesh:

Year:  2013        PMID: 22975872      PMCID: PMC3713461          DOI: 10.1007/978-1-4614-4433-6_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  195 in total

1.  Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells.

Authors:  G Penna; S Sozzani; L Adorini
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

2.  HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms.

Authors:  R Cai; B Carpick; R F Chun; K T Jeang; B R Williams
Journal:  Arch Biochem Biophys       Date:  2000-01-15       Impact factor: 4.013

3.  Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Authors:  Angela Meier; J Judy Chang; Ellen S Chan; Richard B Pollard; Harlyn K Sidhu; Smita Kulkarni; Tom Fang Wen; Robert J Lindsay; Liliana Orellana; Donna Mildvan; Suzane Bazner; Hendrik Streeck; Galit Alter; Jeffrey D Lifson; Mary Carrington; Ronald J Bosch; Gregory K Robbins; Marcus Altfeld
Journal:  Nat Med       Date:  2009-07-13       Impact factor: 53.440

4.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

5.  IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation.

Authors:  Anne Krug; Ravindra Uppaluri; Fabio Facchetti; Brigitte G Dorner; Kathleen C F Sheehan; Robert D Schreiber; Marina Cella; Marco Colonna
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 6.  Lessons learned from the natural hosts of HIV-related viruses.

Authors:  Mirko Paiardini; Ivona Pandrea; Cristian Apetrei; Guido Silvestri
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

7.  IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.

Authors:  Babak Baban; Phillip R Chandler; Madhav D Sharma; Jeanene Pihkala; Pandelakis A Koni; David H Munn; Andrew L Mellor
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

8.  Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.

Authors:  Thalie Devosse; Aude Guillabert; Nicky D'Haene; Alix Berton; Patricia De Nadai; Sophie Noel; Maryse Brait; Jean-Denis Franssen; Silvano Sozzani; Isabelle Salmon; Marc Parmentier
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection.

Authors:  Kevin N Brown; Viskam Wijewardana; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

10.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  34 in total

Review 1.  A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection.

Authors:  Franck J Barrat; Lishan Su
Journal:  J Exp Med       Date:  2019-08-16       Impact factor: 14.307

Review 2.  Type I interferon: understanding its role in HIV pathogenesis and therapy.

Authors:  Steven E Bosinger; Netanya S Utay
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

Review 3.  HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.

Authors:  Sho Sugawara; David L Thomas; Ashwin Balagopal
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-15       Impact factor: 2.205

4.  The immune response fails to control HIV early in initial virus spread.

Authors:  Lillian B Cohn; Steven G Deeks
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals.

Authors:  Kateena Addae Konadu; Ming Bo Huang; William Roth; Wendy Armstrong; Michael Powell; Francois Villinger; Vincent Bond
Journal:  J Vis Exp       Date:  2016-01-05       Impact factor: 1.355

6.  Differential partial activation phenotype and production of tumour necrosis factor-α by conventional dendritic cells in response to lipopolysaccharide in HIV+ viraemic subjects and HIV+ controllers.

Authors:  R Camacho-Sandoval; P M Del Río Estrada; A Rivero-Arrieta; G Reyes-Terán; L C Bonifaz
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

7.  Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.

Authors:  Georgia N Ambada; Claudine E Ntsama; Nadesh N Nji; Loveline N Ngu; Carole N Sake; Abel Lissom; Flaurent T Tchouangeu; Jules Tchadji; Martin Sosso; François-Xavier Etoa; Godwin W Nchinda
Journal:  Immunology       Date:  2017-05-18       Impact factor: 7.397

Review 8.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

9.  Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.

Authors:  Bin Su; Alexandre Lederle; Géraldine Laumond; Camille Ducloy; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Hallmarks of HIV-1 pathogenesis are modulated by Nef's Secretion Modification Region.

Authors:  Kateena Addae Konadu; Joseph S Anderson; Ming-Bo Huang; Syed A Ali; Michael D Powell; Francois Villinger; Vincent C Bond
Journal:  J AIDS Clin Res       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.